The global blood culture tests market is projected to reach USD 6.1 billion by 2025 from USD 4.0 billion in 2020, at a CAGR of 8.9%. Growth in this market is mainly driven by the increasing number of sepsis cases and high cost of treatment, rising geriatric population, high incidence of bloodstream infections, growth in the demand for rapid diagnostic techniques, and the high prevalence of infectious diseases. On the other hand, factors such as the high cost of automated instruments and a lack of skilled laboratory technicians are limiting the growth of this market.
The major players in the blood culture tests market are Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), and bioMérieux SA (France). Analysis of the market developments between 2016 and October 2020 revealed that partnerships & agreements, product launches, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the blood culture tests market.
To know about the assumptions considered for the study download the pdf brochure
BECTON, DICKINSON AND COMPANY (US)
The company was the leading player in the global blood culture tests market, in 2019. The leading position of the company is majorly attributed to its strong brand image and robust product portfolio. Being an innovation-centric company, the company significantly focuses on research and development (R&D) activities to develop and launch advanced products in the market. For instance, the company obtained the CE mark approval for the BD Vacutainer UltraTouch Push Button Blood Collection Set (BCS) with Preattached Holder. Such approvals will help the company to expand its product offerings in the blood culture tests market.
BIOMÉRIEUX SA (FRANCE)
bioMérieux accounted for the second-largest share of the global blood culture tests market in 2019. The leading position of the company is attributed to its strong brand recognition. The company focuses on organic growth strategies to expand its presence in the blood culture tests market. In 2017, the company received FDA clearance for BPA and BPN culture bottles used with BACT/ALERT VIRTUO for the quality control testing of platelets.
THERMO FISHER SCIENTIFIC (US)
Thermo Fisher Scientific was the third-largest player in the blood culture tests market, in 2019. The company has a strong portfolio of blood culture products, including blood culture instruments, blood culture instrument software, blood culture instrument accessories, blood culture media, and mycobacteria culture systems.
Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) - Global Forecast to 2025
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE